Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 15601812108 |
| E-mail: | lixing@pharmahuici.com |
| QQ: | 2986398005 |
| Skype: | Chat Now! |
| Address: | Shanghai Huici Pharmaceutical Technology Co., LTD |
|
Shanghai Huici Pharmaceutical Technology Co., Ltd. is a high-end chemical supplier integrating R&D, production and trade. It is committed to providing one-stop solutions for small molecule drugs from API to preparation, from preclinical to commercialization for domestic and foreign research institutes, pharmaceutical companies, R&D outsourcing enterprises and global partners. Focusing on the management of pharmaceutical intermediates, apis, preparations, medical devices and other products, Huici Pharmaceutical will provide high-quality services for high-quality pharmaceutical enterprises at home and abroad with high-quality product quality.
Huici Pharmaceutical is located in Pudong New District, Shanghai, with an experienced quality management team, established a standardized and perfect quality standard system, from the enterprise risk assessment, product development, transfer and amplification, manufacturing, inspection, sales and service supervision and management of the whole process, for the continuous and stable production of products in line with customer quality standards to provide a reliable guarantee. It has established long-term cooperative relations with Shanghai Institute of Organic Chemistry, Shanghai Institute of Materia Medica and Shanghai Medical Engineering Institute.
|
|
| Product Name | MF | CAS | Details |
|---|
| Netupitant | C30H32F6N4O | 290297-26-6 | Details |
| Naltrexone hydrochloride | C20H24ClNO4 | 16676-29-2 | Details |
| Apixaban | C25H25N5O4 | 503612-47-3 | Details |
| Dapagliflozin | C21H25ClO6 | 461432-26-8 | Details |
| Rucaparib | C19H21FN3O5P | 459868-92-9 | Details |
| Tofacitinib citrate | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
| Sarecycline hydrochloride | C24H30ClN3O8 | 1035979-44-2 | Details |
| Tamoxifen | C26H29NO | 10540-29-1 | Details |
| Nilotinib | C28H22F3N7O | 641571-10-0 | Details |
| Bilastine | C28H37N3O3 | 202189-78-4 | Details |
| Palonosetron Hydrochloride | C19H25ClN2O | 135729-62-3 | Details |
| Ribociclib | C23H30N8O | 1211441-98-3 | Details |
| Mertansine | C35H48ClN3O10S | 139504-50-0 | Details |
| Carfilzomib | C40H57N5O7 | 868540-17-4 | Details |
| Cerdulatinib | C20H27N7O3S | 1198300-79-6 | Details |
| Lorlatinib | C21H19FN6O2 | 1454846-35-5 | Details |
| Dolutegravir sodium | C20H20F2N3NaO5 | 1051375-19-9 | Details |
| Gefitinib | C22H24ClFN4O3 | 184475-35-2 | Details |
| Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
| Ensartinib | C25H25Cl2FN6O3 | 1365267-27-1 | Details |
| Sancycline | C21H22N2O7 | 808-26-4 | Details |
| Fasiglifam | C29H32O7S | 1000413-72-8 | Details |
| Tolvaptan | C26H25ClN2O3 | 150683-30-0 | Details |
| Nintedanib | C31H33N5O4 | 656247-17-5 | Details |
| Lopinavir | C37H48N4O5 | 192725-17-0 | Details |
| Ramelteon | C16H21NO2 | 196597-26-9 | Details |
| Tivozanib | C22H19ClN4O5 | 475108-18-0 | Details |
| Trilaciclib | C24H30N8O | 1374743-00-6 | Details |
| Umbralisib | C31H24F3N5O3 | 1532533-67-7 | Details |
| Tepotinib | C29H28N6O2 | 1100598-32-0 | Details |
| Denosumab | C6404H9912N1724O2004S50 | 615258-40-7 | Details |
| Imatinib mesylate | C30H35N7O4S | 220127-57-1 | Details |
| D-Luciferin potassium salt | C11H9KN2O3S2 | 115144-35-9 | Details |
| Docetaxel | C43H53NO14 | 114977-28-5 | Details |
| Ethynyl estradiol | C20H24O2 | 57-63-6 | Details |
| Side chain for meropenem | C15H19N3O5S | 96034-64-9 | Details |
| Pemetrexed Disodium | C20H22N5NaO6 | 150399-23-8 | Details |
| Mycophenolate mofetil | C23H31NO7 | 115007-34-6 | Details |
| Temozolomide | C6H6N6O2 | 85622-93-1 | Details |
| 4,5-diiodo-1-methyl-triazole | C3H3I2N3 | 1248676-71-2 | Details |
| 4-Fluoro-7-hydroxy-1-indanone | C9H7FO2 | 136191-16-7 | Details |
| 6-bromo-2-methylpyrazolo[1,5-a]pyrimidine | C7H6BrN3 | 916256-65-0 | Details |
| Methyl 3-(4-Chlorophenyl)propiolate | C10H7ClO2 | 7515-18-6 | Details |
| 5-Bromobenzo[c][1,2,5]oxadiazole | C6H3BrN2O | 51376-06-8 | Details |
| tert-butyl 2-(2-bromoethoxy)ethylcarbamate | C9H18BrNO3 | 164332-88-1 | Details |
| 1-Boc-azetidine-2-carboxylic acid | C9H15NO4 | 159749-28-7 | Details |
| 1-Aminocyclobutanecarboxylic acid | C5H9NO2 | 22264-50-2 | Details |
| DEBIO-1347 | C20H16N6O | 1265229-25-1 | Details |
| 2-bromo-4-chloro-5-fluorophenol | C6H3BrClFO | 157165-23-6 | Details |
| 2-Fluoro-4-methoxy-1-(trifluoromethyl)benzene | C8H6F4O | 1214344-33-8 | Details |
| 5-(tert-butoxycarbonylaminomethyl)furan-2-sulfonamide | C10H16N2O5S | 1094667-31-8 | Details |
| Methyl tetrahydro-2H-pyran-2-carboxylate | C7H12O3 | 84355-44-2 | Details |
| Benzenamine | C12H11N5O | 2131230-56-1 | Details |
| tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate | C10H18N2O2 | 1041026-70-3 | Details |
| Azadibenzocylooctyne-amine | C18H16N2O | 1255942-06-3 | Details |
| Mc-Val-Cit-PABC-PNP | C35H43N7O11 | 159857-81-5 | Details |
| DBCO-NHS | C23H18N2O5 | 1353016-71-3 | Details |
| Mc-Val-Cit-PABC-PNP | C28H40N6O7 | 159857-80-4 | Details |
| Desthiobiotin-Iodoacetamide | 2924824-04-2 | Details |
| Py-MAA-Val-Cit-PAB-MMAE | C72H111N13O16S | 2247398-68-9 | Details |
| 3,3`-Dithiobispropanoic acid bis(N-hydroxysuccinimde ester) | C14H16N2O8S2 | 57757-57-0 | Details |
| FMOC-3AA-OH | C36H51N3O7 | 863971-44-2 | Details |
| Val-Cit-PAB | C18H29N5O4 | 159857-79-1 | Details |
| FMoc-Val-Cit-PAB-PNP | C40H42N6O10 | 863971-53-3 | Details |
| Disuccinimidyl glutarate | C13H14N2O8 | 79642-50-5 | Details |
| Boc-Dap-NE | C23H36N2O5 | 160800-65-7 | Details |
| 3-(2-Pyridyldithio)propionic Acid N-Succinimidyl Ester | C12H12N2O4S2 | 68181-17-9 | Details |
| FMoc-Val-Cit-PAB-PNP | C33H39N5O6 | 159858-22-7 | Details |
| MAC glucuronide linker-2 | C20H25NO11 | 229977-57-5 | Details |
| MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH | C28H36N6O10 | 1599440-25-1 | Details |
| DBCO-Acid | C19H15NO3 | 1353016-70-2 | Details |
| Fmoc-Gly-Gly-Phe-OH | C28H27N3O6 | 160036-44-2 | Details |
| Fmoc-AEEA-OH | C21H23NO6 | 166108-71-0 | Details |
| BocNH-PEG23-CH2CH2NH2 | C26H33NO8 | 557756-85-1 | Details |
| N-Butanoyl-L-homoserine lactone | C8H13NO3 | 67605-85-0 | Details |
| 2,5-dioxopyrrolidin-1-yl 4-(pyridin-2-yldisulfanyl)butanoate | C13H14N2O4S2 | 115088-06-7 | Details |
| Fmoc-D-Trp(Boc)-OH | C31H30N2O6 | 163619-04-3 | Details |
| MC-Val-Ala-PAB-PNP | C32H37N5O10 | 1639939-40-4 | Details |
| S-(1-Hydroxy-2-methylpropan-2-yl) methanesulfonothioate | C5H12O3S2 | 2127875-65-2 | Details |
| Boc-NH-PEG4-bromide | C13H26BrNO5 | 1076199-21-7 | Details |
| MC-Gly-Gly-Phe | C23H28N4O7 | 1599440-15-9 | Details |
| MC-Gly-Gly-Phe-Gly | C25H31N5O8 | 2413428-36-9 | Details |
| Boc-Val-Cit-OH | C16H30N4O6 | 870487-08-4 | Details |
| BOC-GLY-GLY-PHE-GLY-OH | C20H28N4O7 | 187794-49-6 | Details |
| sulfo-SPDB | C13H14N2O7S3 | 1193111-39-5 | Details |
| DBCO-PEG5-NHS ester | C36H43N3O11 | 2144395-59-3 | Details |
| DBCO-CONH-S-S-NHS ester | C28H27N3O6S2 | 1435934-53-4 | Details |
| 2-[2-(2-t-Boc-aminoethoxy]ethoxy]ethyl Bromide | C11H22BrNO4 | 165963-71-3 | Details |
| N-succinimidyl 4-(2-pyridyldithio)pentanoate | C14H16N2O4S2 | 341498-08-6 | Details |
| DBCO-Maleimide | C25H21N3O4 | 1395786-30-7 | Details |
| Mal-PEG4-Val-Cit-PAB-PNP | C40H53N7O15 | 2112738-09-5 | Details |
| SPDMV | C15H18N2O4S2 | 890409-85-5 | Details |
| Mal-PEG2-VCP-NB | C36H45N7O13 | 2395887-69-9 | Details |
| Boc-NH-PEG4-CH2CH2COOH | C16H31NO8 | 756525-91-4 | Details |
| Mal-PEG1-NHS ester | C13H14N2O7 | 1807518-72-4 | Details |
| Tapinarof | C17H18O2 | 79338-84-4 | Details |
| Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
| Cyclooctyne-O-NHS ester | C14H17NO5 | 1425803-45-7 | Details |
| Retigabine Dihydrochloride | C16H20Cl2FN3O2 | 150812-13-8 | Details |
| Retigabine | C16H18FN3O2 | 150812-12-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 | ||||